Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2019

Open Access 01-08-2019 | Polio Virus | Original Article

Enteroviral meningitis reduces CSF concentration of Aβ42, but does not affect markers of parenchymal damage

Authors: Kacper Toczylowski, Malgorzata Wojtkowska, Artur Sulik

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2019

Login to get access

Abstract

Biomarkers classically studied in Alzheimer’s disease have been analyzed in numerous central nervous system infections in adults, but there are scarce data on these biomarkers in children. Enteroviruses appear to be the most common cause of aseptic meningitis throughout the world. The aim of the study was to investigate neuroinflammatory properties of non-polio enteroviruses by measuring CSF concentrations of biomarkers that are involved in neuropathological pathways of neurodegenerative disorders. We measured Aβ42, t-tau, and S100B concentrations in 42 children with enteroviral meningitis (EM) compared to control group without central nervous system infection. We found enteroviral meningitis (EM) to reduce CSF concentration of Aβ42 (median, 1051.1 pg/mL; interquartile range (IQR), 737.6–1559.5 vs. median, 459.4 pg/mL; IQR, 312.0–662.0, p < 0.001). In contrast, CSF concentrations of t-tau and S100B were not affected by EM. There was a correlation between total neutrophil count in CSF and Aβ42 (R = − 0.59, p < 0.001). Absolute number of mononuclear cells in the CSF correlated with CSF t-tau (R = 0.41, p < 0.05). Both correlations remained significant after adjustment for age, blood leukocytes, serum CRP, CSF leukocytes, and CSF protein concentration.
Literature
1.
go back to reference Itzhaki RF (2017) Herpes simplex virus type 1 and Alzheimer’s disease: possible mechanisms and signposts. FASEB J 31:3216–3226CrossRefPubMed Itzhaki RF (2017) Herpes simplex virus type 1 and Alzheimer’s disease: possible mechanisms and signposts. FASEB J 31:3216–3226CrossRefPubMed
2.
go back to reference Zhan X, Stamova B, Jin L-W, DeCarli C, Phinney B, Sharp FR (2016) Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87:2324–2332CrossRefPubMedPubMedCentral Zhan X, Stamova B, Jin L-W, DeCarli C, Phinney B, Sharp FR (2016) Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87:2324–2332CrossRefPubMedPubMedCentral
3.
go back to reference Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95–130CrossRefPubMed Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95–130CrossRefPubMed
4.
go back to reference Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (N Y) 4:575–590 Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (N Y) 4:575–590
6.
go back to reference Rohlwink UK, Mauff K, Wilkinson KA, Enslin N, Wegoye E, Wilkinson RJ, Figaji AA (2017) Biomarkers of cerebral injury and inflammation in pediatric tuberculous meningitis. Clin Infect Dis 65:1298–1307CrossRefPubMedPubMedCentral Rohlwink UK, Mauff K, Wilkinson KA, Enslin N, Wegoye E, Wilkinson RJ, Figaji AA (2017) Biomarkers of cerebral injury and inflammation in pediatric tuberculous meningitis. Clin Infect Dis 65:1298–1307CrossRefPubMedPubMedCentral
7.
go back to reference Chaves ML, Camozzato AL, Ferreira ED, Piazenski I, Kochhann R, Dall’Igna O, Mazzini GS, Souza DO, Portela LV (2010) Serum levels of S100B and NSE proteins in Alzheimer’s disease patients. J Neuroinflammation 7:6CrossRefPubMedPubMedCentral Chaves ML, Camozzato AL, Ferreira ED, Piazenski I, Kochhann R, Dall’Igna O, Mazzini GS, Souza DO, Portela LV (2010) Serum levels of S100B and NSE proteins in Alzheimer’s disease patients. J Neuroinflammation 7:6CrossRefPubMedPubMedCentral
8.
go back to reference Alshweki A, Pérez-Muñuzuri A, López-Suárez O, Baña A, Couce ML (2017) Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia. Medicine (Baltimore) 96:8453CrossRef Alshweki A, Pérez-Muñuzuri A, López-Suárez O, Baña A, Couce ML (2017) Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia. Medicine (Baltimore) 96:8453CrossRef
9.
go back to reference Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M (2013) Cerebrospinal fluid Alzheimer’s biomarker profiles in CNS infections. J Neurol 260:620–626CrossRefPubMed Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M (2013) Cerebrospinal fluid Alzheimer’s biomarker profiles in CNS infections. J Neurol 260:620–626CrossRefPubMed
10.
go back to reference Sjögren M, Gisslén M, Vanmechelen E, Blennow K (2001) Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett 314:33–36CrossRefPubMed Sjögren M, Gisslén M, Vanmechelen E, Blennow K (2001) Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett 314:33–36CrossRefPubMed
11.
go back to reference Spitzer P, Lang R, Oberstein TJ, Lewczuk P, Ermann N, Huttner HB, Masouris I, Kornhuber J, Ködel U, Maler JM (2018) A specific reduction in Aβ1-42 vs. a universal loss of Aβ peptides in CSF differentiates Alzheimer’s disease from meningitis and multiple sclerosis. Front Aging Neurosci 10:152CrossRefPubMedPubMedCentral Spitzer P, Lang R, Oberstein TJ, Lewczuk P, Ermann N, Huttner HB, Masouris I, Kornhuber J, Ködel U, Maler JM (2018) A specific reduction in Aβ1-42 vs. a universal loss of Aβ peptides in CSF differentiates Alzheimer’s disease from meningitis and multiple sclerosis. Front Aging Neurosci 10:152CrossRefPubMedPubMedCentral
12.
go back to reference Spitzer P, Condic M, Herrmann M et al (2016) Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity. Sci Rep 6:32228CrossRefPubMedPubMedCentral Spitzer P, Condic M, Herrmann M et al (2016) Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity. Sci Rep 6:32228CrossRefPubMedPubMedCentral
13.
go back to reference Soscia SJ, Kirby JE, Washicosky KJ et al (2010) The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5:9505CrossRef Soscia SJ, Kirby JE, Washicosky KJ et al (2010) The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5:9505CrossRef
14.
go back to reference Süssmuth SD, Reiber H, Tumani H (2001) Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases. Neurosci Lett 300:95–98CrossRefPubMed Süssmuth SD, Reiber H, Tumani H (2001) Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases. Neurosci Lett 300:95–98CrossRefPubMed
15.
go back to reference Collins-Praino LE, Corrigan F (2017) Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury? Brain Behav Immun 60:369–382CrossRefPubMed Collins-Praino LE, Corrigan F (2017) Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury? Brain Behav Immun 60:369–382CrossRefPubMed
16.
go back to reference Jung K, Goerdt C, Lange P, Blocher J, Djukic M, Gerber J, Spreer A, Nau R, Otto M, Schmidt H (2011) The use of S100B and tau protein concentrations in the cerebrospinal fluid for the differential diagnosis of bacterial meningitis: a retrospective analysis. Eur Neurol 66:128–132CrossRefPubMed Jung K, Goerdt C, Lange P, Blocher J, Djukic M, Gerber J, Spreer A, Nau R, Otto M, Schmidt H (2011) The use of S100B and tau protein concentrations in the cerebrospinal fluid for the differential diagnosis of bacterial meningitis: a retrospective analysis. Eur Neurol 66:128–132CrossRefPubMed
17.
go back to reference Mattsson N, Bremell D, Anckarsäter R, Blennow K, Anckarsäter H, Zetterberg H, Hagberg L (2010) Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol 10:51CrossRefPubMedPubMedCentral Mattsson N, Bremell D, Anckarsäter R, Blennow K, Anckarsäter H, Zetterberg H, Hagberg L (2010) Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol 10:51CrossRefPubMedPubMedCentral
18.
go back to reference Gazzolo D, Grutzfeld D, Michetti F, Toesca A, Lituania M, Bruschettini M, Dobrzanska A, Bruschettini P (2004) Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: relationship to brain damage and routine cerebrospinal fluid findings. Clin Chem 50:941–944CrossRefPubMed Gazzolo D, Grutzfeld D, Michetti F, Toesca A, Lituania M, Bruschettini M, Dobrzanska A, Bruschettini P (2004) Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: relationship to brain damage and routine cerebrospinal fluid findings. Clin Chem 50:941–944CrossRefPubMed
19.
go back to reference Peng Q-L, Tao S-H, Yu N, Zhou X-Z, Peng Y-Z, Fu N (2017) Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections. Int J Neurosci 127:1–9CrossRefPubMed Peng Q-L, Tao S-H, Yu N, Zhou X-Z, Peng Y-Z, Fu N (2017) Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections. Int J Neurosci 127:1–9CrossRefPubMed
20.
go back to reference Negrini B, Kelleher KJ, Wald ER (2000) Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 105:316–319CrossRefPubMed Negrini B, Kelleher KJ, Wald ER (2000) Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 105:316–319CrossRefPubMed
22.
go back to reference Duits FH, Teunissen CE, Bouwman FH et al (2014) The cerebrospinal fluid “Alzheimer profile”: easily said, but what does it mean? Alzheimers Dement 10:713–723 e2CrossRefPubMed Duits FH, Teunissen CE, Bouwman FH et al (2014) The cerebrospinal fluid “Alzheimer profile”: easily said, but what does it mean? Alzheimers Dement 10:713–723 e2CrossRefPubMed
23.
go back to reference Handoko M, Grant M, Kuskowski M, Zahs KR, Wallin A, Blennow K, Ashe KH (2013) Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults. JAMA Neurol 70:594–599CrossRefPubMedPubMedCentral Handoko M, Grant M, Kuskowski M, Zahs KR, Wallin A, Blennow K, Ashe KH (2013) Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults. JAMA Neurol 70:594–599CrossRefPubMedPubMedCentral
Metadata
Title
Enteroviral meningitis reduces CSF concentration of Aβ42, but does not affect markers of parenchymal damage
Authors
Kacper Toczylowski
Malgorzata Wojtkowska
Artur Sulik
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03569-0

Other articles of this Issue 8/2019

European Journal of Clinical Microbiology & Infectious Diseases 8/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.